Skip to main content
TipRanks
Go Ultimate75% OFF

Amphastar Pharmaceuticals (AMPH) Income Statement

437 Followers

Amphastar Pharmaceuticals Income Statement

Last quarter (Q3 2026), Amphastar Pharmaceuticals's total revenue was $207.61M, an increase of 8.22% from the same quarter last year. In Q3, Amphastar Pharmaceuticals's net income was $37.76M. See Amphastar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 719.89M$ 731.97M$ 644.39M$ 498.99M$ 437.77M
$ 356.06M$ 373.86M$ 351.12M$ 248.86M$ 199.74M
$ 215.65M$ 168.44M$ 154.13M$ 141.36M$ 129.85M
Depreciation and Amortization$ 63.20M$ 57.20M$ 41.78M$ 28.27M$ 25.46M
$ 212.31M$ 277.31M$ 240.29M$ 146.16M$ 110.49M
$ 140.40M$ 205.42M$ 196.99M$ 107.50M$ 69.89M
$ -16.78M$ -16.23M$ -27.61M$ 7.37M$ 14.04M
$ 123.62M$ 189.19M$ 169.38M$ 114.86M$ 83.93M
$ 98.09M$ 159.52M$ 137.54M$ 91.39M$ 62.12M
Per Share Metrics
Basic EPS$ 2.10$ 3.29$ 2.85$ 1.88$ 1.30
Diluted EPS$ 2.03$ 3.06$ 2.60$ 1.74$ 1.25
Weighted Average Shares Outstanding46.74M48.43M48.27M48.55M47.78M
Weighted Average Shares Outstanding (Diluted)48.22M52.06M53.00M52.43M49.78M

Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

-400M0400M800M-12 %0 %12 %24 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin